Arena Capital Advisors, LLC- CA - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 33 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Arena Capital Advisors, LLC- CA ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$5,737
+473.7%
19,2510.0%0.00%
Q3 2022$1,000
-85.7%
19,251
-72.2%
0.00%
-100.0%
Q2 2022$7,000
-50.0%
69,2510.0%0.00%0.0%
Q1 2022$14,000
-76.7%
69,251
-31.0%
0.00%
-66.7%
Q4 2021$60,000
-3.2%
100,2990.0%0.01%
+20.0%
Q3 2021$62,000
+158.3%
100,299
+301.2%
0.01%
+150.0%
Q2 2021$24,00025,0000.00%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 133,332$39,7330.09%
ANGELO GORDON & CO., L.P. 13,333$134,6630.02%
Radcliffe Capital Management, L.P. 66,566$672,3170.02%
Dryden Capital, LLC 15,000$4,4700.01%
METEORA CAPITAL, LLC 50,000$14,9000.00%
Arena Capital Advisors, LLC- CA 19,251$5,7370.00%
MMCAP International Inc. SPC 73,525$21,9100.00%
PERISCOPE CAPITAL INC. 196,896$57,5710.00%
MARSHALL WACE, LLP 36,056$364,1650.00%
CLEAR STREET LLC 217,000$650.00%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders